Tylenol is owned by Kenvue, a company that was spun off from Johnson & Johnson in 2023. Kenvue is an American consumer health enterprise headquartered in Summit, New Jersey, and it took over the Tylenol brand, which was originally introduced in 1955 by McNeil Laboratories before Johnson & Johnson acquired McNeil in 1959. Kenvue now manages Tylenol along with other consumer health products such as Band-Aid, Listerine, Neutrogena, and Aveeno.